FOXP3+T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFαAgents

Comparative Efficacy of Biologics in Psoriasis

(2012) Iris H. Kim et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease

(2012) J. Grundström et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease

(2012) Pierre Desreumaux et al.   GASTROENTEROLOGY

Regulatory T-Cell Therapy for Crohn's Disease: In Vivo Veritas

(2012) Silvio Danese et al.   GASTROENTEROLOGY

Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma

(2012) Giuseppina Bonanno et al.   Journal of Translational Medicine

The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4+CD25+ regulatory T cells

(2012) Ji Seon Oh et al.   RHEUMATOLOGY INTERNATIONAL

Rheumatoid arthritis and the era of biologic therapy

(2012) Anshuman P. Malaviya et al.   INFLAMMOPHARMACOLOGY

Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNF  treatment

(2011) C. Veltkamp et al.   GUT

Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells

(2011) Anders Dige et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update

(2010) Veruscka Leso et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Peripheral regulatory T cells and serum transforming growth factor-β: Relationship with clinical response to infliximab in Crohnʼs disease

(2010) Antonio Di Sabatino et al.   INFLAMMATORY BOWEL DISEASES

Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab†

(2010) Zhe Li et al.   INFLAMMATORY BOWEL DISEASES

Therapy with anti-TNFα antibody enhances number and function of Foxp3+ regulatory T cells in inflammatory bowel diseases

(2010) Gilles Boschetti et al.   INFLAMMATORY BOWEL DISEASES

From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome

(2009) A. Blanco Quirós et al.   ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Circulating CD4+CD25brightFOXP3+ T Cells Are Up-Regulated by Biological Therapies and Correlate with the Clinical Response in Psoriasis Patients

(2009) P. Quaglino et al.   DERMATOLOGY

Control of type 1 diabetes by CD4+Foxp3+regulatory T cells: lessons from mouse models and implications for human disease

(2009) Evridiki Sgouroudis et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

CD4+CD25+ regulatory T cells in human lupus erythematosus

(2008) Annegret Kuhn et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Anti tumour necrosis-α therapy increases the number of FOXP3+regulatory T cells in children affected by Crohn’s disease

(2008) Ida Ricciardelli et al.   IMMUNOLOGY

Multiple Sclerosis and Regulatory T Cells

(2008) Cristina Maria Costantino et al.   JOURNAL OF CLINICAL IMMUNOLOGY